Positive impactCompany

Jio Platforms: Nomura Initiates With 'Buy', Sees 20% Upside; Why Cash Flow Could Be The Next Big Trigger

NDTV Profit 58 min ago·28 Oct 2026, 2:53 am
JPL NDTV Profit

Japanese brokerage Nomura has initiated coverage on Jio Platforms with a 'Buy' rating, projecting a potential upside of 20% for the stock. This positive outlook is primarily driven by the company's improving free cash flow, which is expected to strengthen significantly in the coming quarters. As a key player in India's digital ecosystem, Jio's ability to generate consistent cash is viewed as a critical factor for its future valuation.

For investors, this development highlights Jio's transition from a growth story focused on subscriber acquisition to one centered on operational efficiency and profitability. The brokerage's focus on cash flow suggests that the market is beginning to price in the company's long-term sustainability. This shift in narrative could be a key differentiator for the stock's performance in the near term.

Moving forward, investors should closely monitor the company's quarterly earnings reports to see if the cash flow generation aligns with Nomura's expectations. Any positive surprises regarding operational metrics or strategic partnerships could further support the stock's upward trajectory.

Affected stocks

Bullish1 stock

Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.

Key takeaways

  • Concerns Jio Platforms (JPL).
  • Category: Company.
  • AI reads the tone as positive (potentially bullish) for the stock.

Why it matters

A routine update for Jio Platforms. The tone is positive — historically associated with upward pressure, though not predictive. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at NDTV Profit.

More Company news

More news

Latest headlines

More news

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.